Clinical Trials Market to Exceed USD 83.5 billion by 2030, Garnering 5.4% CAGR – Exclusive Report by Transparency Market Research
September 27, 2023 08:13 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The clinical trials market was estimated to have acquired US$ 46.7 billion in 2019. It is...
Global In Silico Clinical Trials Market 2023-2030: Overcoming Challenges in Protein Flexibility and Molecule Conformation - The Road Ahead for In Silico Clinical Trials
September 27, 2023 06:28 ET
|
Research and Markets
Dublin, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The "Global In Silico Clinical Trials Market by Therapeutic Area (Infectious Diseases, Oncology), Phase (Phase I, Phase II, Phase III), Industry -...
Oligonucleotide API Market revenue to surpass USD 5 Billion by 2035, says Research Nester
September 27, 2023 06:07 ET
|
Research Nester
New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The global oligonucleotide API market size is projected to expand at ~ 10% CAGR between 2023 and 2035. The market is expected to garner a revenue of USD...
Datacubed Health Launches eClinical Platform App in China, Ensuring Full Compliance and Accessibility
September 26, 2023 09:03 ET
|
Datacubed Health
New York, New York, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Datacubed Health, a leading global provider of innovative solutions for patient engagement and data collection in clinical trials, is excited...
Clinical Trials Support Service Market Size is Expanding at USD 46.14 BN by 2032
September 25, 2023 09:48 ET
|
Precedence Research
Ottawa, Sept. 25, 2023 (GLOBE NEWSWIRE) -- According to Precedence Research, the global clinical trials support service market size is expected to reach around 39.63 billion by 2030. Factors such as...
Novotech Awarded Cell & Gene Therapy CRO Excellence 2023
September 19, 2023 03:56 ET
|
Novotech
SINGAPORE, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has just been awarded for the second consecutive year the Best...
POINT Biopharma and Athebio Announce Partnership to Develop Designed Ankyrin Repeat Protein Targeted Radioligands
September 18, 2023 08:00 ET
|
POINT Biopharma
INDIANAPOLIS and SCHLIEREN-ZURICH, Switzerland, Sept. 18, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery,...
Purdue researcher awarded $1.3 million for malaria drug trials in Southeast Asia and Africa
September 15, 2023 12:48 ET
|
Purdue Research Foundation
WEST LAFAYETTE, Ind., Sept. 15, 2023 (GLOBE NEWSWIRE) -- A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries. Open...
Global Clinical Trial Imaging Market Research Report 2023-2028: Visualizing Medical Research - Rising R&D Investments Boost Clinical Trial Imaging
September 14, 2023 06:53 ET
|
Research and Markets
Dublin, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The "Global Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound, ECHO),...
PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device
September 14, 2023 06:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...